aTyr Pharma, Inc. (LIFE) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
22/25
Growth 5
Margin 3
Expansion 5
Platform 4
Financial 5
latest quarter score
Earnings Reports
- 22
- 25
- 23
- 8